Showing results (701-710 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|September 8, 2000
Pronounced effect of caprylocaproyl macrogolglycerides on nasal absorption of IS-159, a peptide serotonin 1B/1D-receptor agonistJ Dingemanse, C Soubrouillard, J Paris, et al.Clinical Pharmacology and Therapeutics|September 8, 2000
Morphine clearance and effects in newborn infants in relation to gestational ageE Saarenmaa, P J Neuvonen, P Rosenberg, et al.Clinical Pharmacology and Therapeutics|September 8, 2000
Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotypeK Herrlin, A Y Massele, G Rimoy, et al.Clinical Pharmacology and Therapeutics|September 8, 2000
Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6P Damkier, K BrøsenClinical Pharmacology and Therapeutics|November 1, 1975
Oral benzquinamide in the treatment of nausea and vomitingC G Moertel, A J Schutt, R G Hahn, et al.Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 2: phase II investigationsL E Hollister, B L Martz, E A Carr, et al.Clinical Pharmacology and Therapeutics|October 3, 2000
Phage therapy: the peculiar kinetics of self-replicating pharmaceuticalsR J Payne, D Phil, V A JansenClinical Pharmacology and Therapeutics|October 3, 2000
In vivo drug-drug interaction studies--a survey of all new molecular entities approved from 1987 to 1997P J Marroum, R S Uppoor, T Parmelee, et al.Clinical Pharmacology and Therapeutics|June 1, 1975
Morphine and phenytoin binding to plasma proteins in renal and hepatic failureG D Olsen, W M Bennett, G A PorterClinical Pharmacology and Therapeutics|May 1, 1975
Fenfluramine in man: hypophagia associated with diminished serotonin turnoverI Shoulson, T N ChasePageof 941